WO2006019114A1 - ポリフェノール化合物を含有する美白剤 - Google Patents
ポリフェノール化合物を含有する美白剤 Download PDFInfo
- Publication number
- WO2006019114A1 WO2006019114A1 PCT/JP2005/015009 JP2005015009W WO2006019114A1 WO 2006019114 A1 WO2006019114 A1 WO 2006019114A1 JP 2005015009 W JP2005015009 W JP 2005015009W WO 2006019114 A1 WO2006019114 A1 WO 2006019114A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acerola
- ascorbic acid
- melanin production
- composition
- active ingredient
- Prior art date
Links
- -1 polyphenol compound Chemical class 0.000 title claims abstract description 45
- 235000013824 polyphenols Nutrition 0.000 title abstract description 34
- 239000007854 depigmenting agent Substances 0.000 title abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 82
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 69
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims abstract description 66
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 30
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 30
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 30
- 239000003112 inhibitor Substances 0.000 claims abstract description 26
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 150000000996 L-ascorbic acids Chemical class 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 14
- 235000013361 beverage Nutrition 0.000 claims abstract description 13
- 241001640002 Malpighia emarginata Species 0.000 claims abstract 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 45
- 230000008099 melanin synthesis Effects 0.000 claims description 39
- 230000002087 whitening effect Effects 0.000 claims description 33
- 235000010208 anthocyanin Nutrition 0.000 claims description 23
- 229930002877 anthocyanin Natural products 0.000 claims description 23
- 239000004410 anthocyanin Substances 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 20
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 claims description 20
- 229930182470 glycoside Natural products 0.000 claims description 16
- 150000002338 glycosides Chemical class 0.000 claims description 13
- 235000009584 malvidin Nutrition 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 150000002772 monosaccharides Chemical class 0.000 claims description 5
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 30
- 240000003394 Malpighia glabra Species 0.000 description 63
- 230000000694 effects Effects 0.000 description 44
- 102000003425 Tyrosinase Human genes 0.000 description 43
- 108060008724 Tyrosinase Proteins 0.000 description 43
- 230000002401 inhibitory effect Effects 0.000 description 40
- 238000012360 testing method Methods 0.000 description 33
- 239000000047 product Substances 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000000243 solution Substances 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- 238000000605 extraction Methods 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 239000003960 organic solvent Substances 0.000 description 13
- 238000001179 sorption measurement Methods 0.000 description 13
- 235000013399 edible fruits Nutrition 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 12
- REFJWTPEDVJJIY-UHFFFAOYSA-N quercetin Natural products C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 11
- 229930003268 Vitamin C Natural products 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 235000019154 vitamin C Nutrition 0.000 description 11
- 239000011718 vitamin C Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 8
- 235000015203 fruit juice Nutrition 0.000 description 8
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 7
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 7
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 7
- 229960004705 kojic acid Drugs 0.000 description 7
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000005875 quercetin Nutrition 0.000 description 7
- 229960001285 quercetin Drugs 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 150000004636 anthocyanins Chemical class 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 4
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 4
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RRYLZZSYDRTJEL-UHFFFAOYSA-N Delphidin Natural products CCN1CC2(COC)CCC(O)C34C5CC6C(O)C5C(CC6OC)(OC(=O)C)C(C(O)C23)C14 RRYLZZSYDRTJEL-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- ZROGCCBNZBKLEL-FHXNIQKESA-N Astilbin Natural products O([C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 ZROGCCBNZBKLEL-FHXNIQKESA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000001382 Experimental Melanoma Diseases 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 2
- NSZQOXBBEWYGQH-UHFFFAOYSA-N Quercetin-3-rhamnosid Natural products CC1OC(O)C(O)C(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C1O NSZQOXBBEWYGQH-UHFFFAOYSA-N 0.000 description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- ZROGCCBNZBKLEL-MPRHSVQHSA-N astilbin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1C(=O)C2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1 ZROGCCBNZBKLEL-MPRHSVQHSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 150000003841 chloride salts Chemical class 0.000 description 2
- 230000002900 effect on cell Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 2
- QDAMORAIRIHJCS-UHFFFAOYSA-N quercetin 3-rhamnoside Natural products CC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O QDAMORAIRIHJCS-UHFFFAOYSA-N 0.000 description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 150000008265 rhamnosides Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000021055 solid food Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- CQOZJDNCADWEKH-UHFFFAOYSA-N 2-[3,3-bis(2-hydroxyphenyl)propyl]phenol Chemical compound OC1=CC=CC=C1CCC(C=1C(=CC=CC=1)O)C1=CC=CC=C1O CQOZJDNCADWEKH-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- SGNZYJXNUURYCH-UHFFFAOYSA-N 5,6-dihydroxyindole Chemical compound C1=C(O)C(O)=CC2=C1NC=C2 SGNZYJXNUURYCH-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- HBQJTBXZMPSVBP-UHFFFAOYSA-N Cyanidine Natural products OC1=CC(=C2/Oc3cc(O)cc(O)c3C=C2O)C=CC1=O HBQJTBXZMPSVBP-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229930182473 O-glycoside Natural products 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- RFOBAKWGJRIIMU-NXNGTVNRSA-O Pelargonidin 3-rhamnoside Chemical compound O[C@H]1C(O)[C@@H](O)C(C)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C=C1 RFOBAKWGJRIIMU-NXNGTVNRSA-O 0.000 description 1
- RFOBAKWGJRIIMU-TUJYBLGZSA-O Pelargonidin 3-rhamnoside Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)c1c(-c2ccc(O)cc2)[o+]c2c(c(O)cc(O)c2)c1 RFOBAKWGJRIIMU-TUJYBLGZSA-O 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 108010032871 pedin Proteins 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 description 1
- VMXUWOKSQNHOCA-UKTHLTGXSA-N ranitidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-UKTHLTGXSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- LNDCCSBWZAQAAW-UHFFFAOYSA-M sodium hydrogen sulfate sulfuric acid Chemical compound [Na+].OS(O)(=O)=O.OS([O-])(=O)=O LNDCCSBWZAQAAW-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Definitions
- the present invention relates to a melanin production inhibitor, a whitening agent, and a composition for cosmetics, foods and drinks, or pharmaceuticals.
- Acerola is a tropical fruit belonging to the genus Hollytrano, which is native to the Caribbean Islands. Acerola fruit contains about 1,500 mg / 100 g or more of vitamin C, and has recently become known as a plant rich in vitamin C. For vitamin C
- JP-A-10-316533 teaches that a fermented acerola containing no vitamin C has a whitening effect. These are due to the contribution of organic acids or carboxylic acids, but the active body is unknown.
- the physiological action of polyphenol components contained in acerola has also attracted attention!
- the present inventors have found that the acerola contains about 100 to 300 mg ZlOOg of polyphenols including anthocyanin dyes quercetin glycosides, and these acerola polyphenols have an active oxygen scavenging action ( Japanese patent application 2003-375913), glucose absorption inhibitory action (Japanese patent application 2003-375323), maltase inhibitory action and AGE production inhibitory activity (Japanese patent application 2003-314207). It is found to be effective for prevention.
- the color of human skin is influenced by the amount of melanin in the epidermis, the blood flow of capillaries, the thickness of the stratum corneum, and the like.
- the amount of melanin has been reported as the most important factor.
- Melanin pigments are produced by the action of tyrosinase on tyrosine in pigment cells (melanocytes), and tyrosine is oxidized to dopa and dopaquinone. Polymerized via 5, 6-dihydroxyindole, and finally becomes a melanin pigment.
- Pigmentation such as shimika buckwheat is one of the major worries for middle-aged and elderly people and women because the production of melanin pigment is remarkably enhanced by the activity of melanocytes. Therefore, recently, cosmetic compositions for reducing the amount of melanin in the skin and keeping the skin white have been developed. These development efforts are concentrated on whitening agents that suppress the activity of tyrosinase, which plays a central role in the melanin production process as described above. For example, it has been proposed that tyrosinase activity inhibitors such as vitamin C or vitamin C derivatives, arbutin, kojic acid, cysteine, and glutathione are incorporated into cosmetics. Whitening agents using placenta extracts, seaweed extracts (comb, wakame, etc.) and plant extracts (tea, aloe, licorice, etc.) are also known.
- Non-Patent Document 1 describes data indicating that delphizine, cyadin and malvidin have a tyrosinase activity inhibitory action.
- Patent Document 1 Japanese Patent No. 2814094
- Patent Document 2 Japanese Patent Laid-Open No. 10-316533
- Non-Patent Document 1 F.A.Badria and M.A.ElGayyar, Boll.Chim.Farmac.- Anno 140-n. 4, p267-271 (2001)
- the above-described whitening ingredients or whitening agents do not sufficiently exhibit the whitening effect on the skin, have poor stability and solubility in the preparation, and have problems in terms of safety. It is not satisfactory for use.
- an object of the present invention is to provide a whitening agent having a sufficient skin whitening effect.
- the present invention includes the following inventions.
- a melanin production inhibitor containing an acerola-derived polyphenolic compound as an active ingredient containing an acerola-derived polyphenolic compound as an active ingredient.
- Acerola fruit juice or acerola extract strength A melanin production inhibitor containing the obtained acerola labienol fraction as an active ingredient.
- a melanin production inhibitor comprising as an active ingredient an anthocyanin compound or a glycoside thereof (excluding shiazin 3 darcoside) or a physiologically acceptable salt thereof.
- the glycoside is a monosaccharide of which rhamnose, glucose, galactose, mannose, xylose, ribose, arabinose, and darcuronic acid are also selected as a group sugar, or the same or different monosaccharides.
- a whitening agent comprising the melanin production inhibitor according to any one of (1) to (6) as an active ingredient.
- a cosmetic composition comprising the whitening agent according to (7).
- a food and beverage composition comprising the whitening agent according to (7).
- Food / beverage composition comprising 0.1 to 30 g, preferably 0.5 to, LOg of acerola-derived polyphenolic compound per lOOg.
- a composition comprising an acerola-derived polyphenol compound and ascorbic acid or an ascorbic acid derivative, wherein the weight ratio of the acerola-derived polyphenol compound to the ascorbic acid or ascorbic acid derivative is 5: 1 to 1:10, preferably 3: 1 to: L:
- the food and beverage composition that is 2.
- the present invention provides a whitening agent that suppresses skin blackening and is free from side effects.
- This whitening agent is useful in a wide range of fields such as food, cosmetics and pharmaceuticals.
- FIG. 1 is a graph showing tyrosinase inhibitory activity of an acerola juice C18 adsorbed fraction.
- FIG. 2 shows the results of an experiment for confirming the melanin production inhibitory effect using mouse melanoma B16 cells of the C18 adsorbed fraction.
- FIG. 3 is a graph showing tyrosinase inhibitory activity of shia-zin-3 rhamnoside (C3R).
- FIG. 4 is a graph showing the tyrosinase inhibitory activity of pelargogin 3-rhamnoside (P3R).
- the present inventors have found that it has an acerola-derived polyphenolic compound kanranine production inhibitory action (more specifically, a tyrosinase activity inhibitory action), and has completed the present invention.
- polyphenol compounds derived from acerola include anthocyanin-based dyes such as siagin-3-rhamnoside and pelargogin-3-rhamnoside, quercitrin (quercetin-3-rhamnoside), and the like. Quercetin glycosides, and among them, anthocyanin pigments are preferred. These polyphenols have an excellent inhibitory effect on the formation of melanin even as a mixture of a plurality of polyphenolic compounds. When individual polyphenolic compounds exist in an isolated form, In particular, when pelargonidin-3-rhamnoside is present in an isolated form, it is preferable because it has a stronger melanin production inhibitory action.
- acerola there are no particular restrictions on the location of the acerola that is the origin of the polyphenolic compound, such as the fruits, roots, stems, and leaves of acerola. In particular, it is preferable to collect fruit strength.
- fruit refers to the whole fruit including the edible part and the seed part.
- Acerolaca can be collected from polyphenolic compounds by a conventional method.
- the acerola fruit juice obtained by squeezing the acerola fruit or the extract power of the above-mentioned part of the acerola can be appropriately purified and collected.
- a method for obtaining the acerola extract for example, extraction with water or an organic solvent.
- a method of extracting with water containing a hydrophilic organic solvent such as alcohol a method of obtaining a flavonoid-containing extract by allowing a synthetic adsorbent to act on a crude extract extracted with an organic solvent and adsorbing it.
- the type of water that can be used as the extraction solvent is not particularly limited, and may be pure water, purified water, or the like.
- an organic solvent is used as the extraction solvent, either a hydrophilic organic solvent or a hydrophobic organic solvent may be used.
- hydrophilic organic solvent examples include alcohols such as methyl alcohol, ethyl alcohol, glycerin, propylene glycol and 1,3-butylene glycol, acetone, tetrahydrofuran, acetonitrile, 1,4-dioxane, pyridine, dimethyl sulfoxide, N , N-dimethylformamide, and known organic solvents such as acetic acid.
- the hydrophilic organic solvent may be used as a mixture with water.
- hydrophobic organic solvent examples include known organic solvents such as hexane, cyclohexane, carbon tetrachloride, chlorophenol, dichloromethane, 1,2-dichloroethane, jetyl ether, ethyl acetate, benzene, toluene and the like. .
- the above hydrophilic organic solvent and hydrophobic organic solvent can be used alone or in combination of two or more.
- the extraction conditions are not particularly limited, but a preferable temperature range is 5 to 90 ° C, particularly 20 to 40 ° C.
- a preferable temperature range is 5 to 90 ° C, particularly 20 to 40 ° C.
- hydrolysis may occur particularly in polyphenols forming glycosides. Therefore, there is a possibility that the polyphenol obtained by low-temperature extraction and the polyphenol obtained by high-temperature extraction may have different effects. It does not affect the activity intensity of the functionality of polyphenol.
- the extraction time is preferably about 1 to 10 hours, especially about 1 to 2 hours, and the amount of solvent used for extraction is preferably 1 to 20 times the mass ratio of the raw material! /.
- the extraction residue is removed by filtration or centrifugation to obtain an extract.
- This extract can be concentrated if necessary. Further, the same extraction process may be performed on the extraction residue.
- the obtained extract may contain a large amount of sugar and organic acid, it is also preferable to carry out a purification step to remove them.
- the purification treatment include normal phase or reverse phase chromatography, ion exchange chromatography, gel filtration and the like. A combination of these methods can also be used.
- the method of isolating and purifying the above-mentioned acerola juice or acerola extract polyphenolic compound is not particularly limited, and includes, for example, HPLC, synthetic adsorbent chromatography, ion exchange chromatography, gel filtration, etc. Synthetic adsorbent chromatography is preferred.
- the elution conditions are preferably elution with, for example, a 10-50% ethanol solution. Furthermore, since anthocyanin dyes are stable under acidic conditions, it is particularly preferable to add hydrochloric acid or acetic acid to the eluate to make it acidic.
- Acerola juice or acerola extract strength The obtained acerola labienol fraction also has a melanin production inhibitory action.
- the acerola labienol fraction refers to a fraction containing a polyphenol compound eluted from the acerola fruit juice or acerola extract under the above elution conditions by the above-mentioned various chromatography.
- the aserobora triphenol fraction includes the eluate, its concentrate and its dried product.
- the present inventors are not limited to those derived from acerola, but various anthocyanin compounds or glycosides thereof (except for cyadin 3-darcoside) or their physiology. It was found that the salt has a ranin production inhibitory action (more specifically, a tyrosinase activity inhibitory action).
- the present invention also relates to a melanin production inhibitor containing these components as active ingredients.
- anthocyanin compounds include siagin, pelargosine, delphidin, malvidin, pedin and pethugin, and among them, siadin, pelargine. -Gin, delphi-zine, malvidin and p-zine are preferred.
- the term "antasia-gin compound” is a derivative of an anthocyan-din compound in addition to an anthocyan-gin compound. Including those with substantially the same inhibitory action on melanin production. Examples of such a derivative include an acyl isomer and an oxy isomer of an anthocyanin compound.
- glycoside examples include rhamnose, glucose, galactose, mannose, xylose, ribose, arabinose, and dalcuronic acid, and a selected monosaccharide (more preferably rhamnose) or a plurality of the same or different monosaccharides.
- An oligosaccharide composed of a sugar (for example, a disaccharide or a trisaccharide) is preferably bonded to the anthocyanin compound through a glycoside bond (usually an O-glycoside bond).
- the glycosidic bond is usually It is formed by the bonding of a hydroxyl group at the 3rd, 3 ', 5th or 7th position of an anthocyanin compound and a sugar.
- the glycoside is not limited to one molecule of anthocyanin compound combined with one molecule of an anthocyanin compound. It may be a combination of different types of sugar molecules.
- the present invention is based on the knowledge described in Non-Patent Document 1 that delphidin, shiazin, and malvidin have no tyrosinase activity inhibitory action, and is easily obtained by those skilled in the art. It is not something that can be conceived.
- physiologically acceptable salt examples include acid addition salts with organic acids or inorganic acids, such as hydrochloride, hydrobromide, sulfate, bisulfate, phosphate, and acid. Phosphate, acetate, oxalate, maleate, fumarate, succinate, lactate, tartrate, benzoate, succinate, dulconate, saccharate, cyclohexylsulfamic acid Salt, methanesulfonate, p-toluenesulfonate, naphthalenesulfonate.
- organic acids or inorganic acids such as hydrochloride, hydrobromide, sulfate, bisulfate, phosphate, and acid.
- the amount of the acerola-derived polyphenolic compound in the melanin production inhibitor of the present invention is not particularly limited as long as it is an effective amount capable of exhibiting a melanin production inhibitory action.
- the present inventors also surprisingly found that melanin production was superior to when acerola-derived polyphenolic compound or acerola polyphenol fraction or the above-mentioned various polyphenol compounds and ascorbic acid were combined.
- the present inventors have found that an inhibitory action is achieved and have completed the present invention.
- ascorbic acid vitamin C
- vitamin C ascorbic acid
- Ascorbic acid may be provided as a derivative thereof.
- ascorbic acid derivatives include ascorbic acid.
- Metal salts such as potassium, sodium, magnesium and calcium of acid, phosphate esters such as phosphate ester strength, phosphate ester magnesium and phosphate phosphate calcium, sulfate esters such as sulfate sodium sulfate and sulfate potassium Is mentioned.
- the melanin production inhibitor of the present invention contains an acerola-derived polyphenolic compound and an ascorbic acid or ascorbic acid derivative, the acerola-derived polyphenolic compound and an ascorbic acid or ascorbic acid derivative
- the weight ratio of 4: 1 to: L: 8 is preferred V, but is not limited to this range!
- the melanin production inhibitor of the present invention has a skin whitening effect as shown in the Examples. That is, the present invention also relates to a whitening agent containing the above melanin production inhibitor as an active ingredient.
- the whitening agent of the present invention is typically formulated as a component of a cosmetic composition, a food / beverage product composition or a pharmaceutical composition, and can only contribute to skin whitening, preventing skin aging, preventing or treating skin cancer, etc. It is expected to have the effect of.
- cosmetic compositions conventional forms such as cosmetic creams, emulsions, lotions, beauty essences, packs, powders, lip balms, lipsticks, under makeup, foundations, sun cares, bath preparations , Body shampoos, body lotions, soaps, cleansing foams, ointments, jellies, aerosols and the like.
- oil, surfactant, alcohol, moisturizer, antioxidant, whitening agent, ultraviolet absorber, Antibacterial and antifungal agents, pigments, dyes, fragrances and the like can be added as appropriate.
- the amount of the acerola-derived polyphenolic compound in the cosmetic composition of the present invention is not particularly limited as long as it is an effective amount capable of exhibiting a melanin production inhibitory effect when used as a cosmetic product. 0.001 to 4% by weight, preferably 0.04 to 0.8% by weight.
- the weight ratio of the acerola-derived polyphenolic compound to ascorbic acid or ascorbic acid derivative is Preferably it is 5: 1 to 1:10, more preferably 3: 1 to 1: 2, but it is not limited to this range.
- Examples of the form of the food and drink composition include beverages, solid foods, semi-solid foods, etc. It can be a health food. Specific examples of beverages include fruit juice beverages, soft drinks, and alcoholic beverages. Further, it may be in a form that is diluted with water or the like when ingested.
- Examples of the solid food include tablets (tablets) including sugarcane, troches and the like, sugar-coated tablets, granules, powdered drinks, powdered soups, powdered blocks, confectionery such as biscuits, capsules, jelly, etc.
- Examples of semi-solid foods include pastes such as jams and gums such as chewing gum.
- these food and drink compositions can be blended with various components that are usually used as food ingredients as long as the desired effects of the present invention are not impaired.
- examples of other components include water, alcohols, sweeteners, acidulants, colorants, preservatives, fragrances, and excipients. These components can be used alone or in combination.
- the amount of the acerola-derived polyphenolic compound in the food / beverage composition of the present invention is not particularly limited as long as it is an effective amount capable of exerting a melanin production inhibitory effect by eating,
- the food / beverage composition is 0.1 to 30 g, preferably 0.5 to 10 g per lOOg.
- the weight of the acerola-derived polyphenolic compound and ascorbic acid or ascorbic acid derivative is preferably 5: 1 to 1:10, more preferably 3: 1 to 1: 2, but is not limited to this range.
- preparations for oral administration include powders, tablets, granules, fine granules, solutions, capsules, pills, troches, liquids for internal use, suspensions, emulsions, syrups, elixirs, etc. it can.
- preparations for parenteral administration include preparations for nasal administration, enteral administration, and transdermal administration.
- Acerola-derived polyphenols in the pharmaceutical composition of the present invention The amount of the compound is not particularly limited as long as it is an effective amount capable of exhibiting a melanin production inhibitory effect by administration. For example, 0.1 to 30 g per 100 g of a pharmaceutical composition, preferably 0.5. ⁇ : LOg.
- the weight ratio of the acerola-derived polyphenolic compound and ascorbic acid or ascorbic acid derivative is preferably Is 5: 1 to 1:10, more preferably 3: 1 to 1: 2, but is not limited to this range.
- the calibration curve was prepared using catechin as the standard substance. As a result, the total polyphenol content of the C18 adsorption fraction obtained here was 40.7%. Note that the total polyphenol content of the same fraction was initially calculated to be 22%. This value is an incorrect value derived from an error in the measurement or calibration curve creation operation. When a calibration curve was prepared, 40.7% was found to be an appropriate value as described above.
- C3R shiaxin-1-3-rhamnoside
- P3R pelargosin-1-3-rhamnoside
- Example 1 1 / 15M phosphate buffer (pH 6.8) 70 Sample solutions of various concentrations in which the C18 adsorption fraction obtained in Example 1 was dissolved in dimethyl sulfoxide (DMSO) 2 Remashroom-derived tyrosinase (CALZYME Laboratories ) was mixed with 70 ⁇ L (10 U) of the same buffer solution and incubated at 25 ° C. for 10 minutes. 10mM L—DOPA
- Tyrosinase activity inhibition rate (%) (1 -a / b) X 100
- PVPP Poly-vinylpolypyrrolidone
- Example 1 the sample was dissolved in 1Z15M phosphate buffer (pH 6.8), not DMSO.
- the polyphenol content was measured in the same manner as in Example 1. The results are shown in Table 1. As is clear from Table 1, it is considered that the polyphenol component is strongly involved in inhibiting the tyrosinase activity of the C18 adsorbed fraction. It is.
- mice-derived B 16 melanoma cells were used for whitening at the cell level.
- An effect confirmation test was conducted. According to this test method, by using animal cells, it is possible to confirm the melanin production inhibitory action and the effect on cell proliferation in an environment closer to the living body.
- B16 melanoma cells derived from mice were seeded in lxl0 5 cells ZmL in a petri dish and cultured at 37 ° C under 5% CO for 2 days. After removing the culture solution, add the C18 adsorption fraction to 10, 50, 75 or
- test medium supplemented with each concentration of 100 / z gZmL was added with lOmLZdish and further cultured at 37 ° C under 5% CO for 3 days. After removing the culture solution, remove the cells with trypsin solution.
- Example 2 Using the two types of acerola-derived polyphenols C3R and P3R obtained in Example 2, a tyrosinase activity inhibition test was performed according to the procedure of Example 3. The results are shown in Figs. From Fig. 3 and Fig. 4, C3R and P3R showed an inhibitory effect on tyrosinase activity. The concentrations of C3R, P3R and kojic acid at which the tyrosinase activity was inhibited by 50% were calculated and shown in Table 2. Kojic acid, well known as a tyrosinase activity inhibitor, was used as a positive control.
- Ascorbic acid (vitamin C) is mainly produced by the reducing action of tyrosinase. It is known that it has the effect of suppressing the generation of hydrogen. Therefore, we investigated the synergistic effect of tyrosinase inhibitory activity of ascorbic acid and C18 adsorbed fraction. Suppression of melanin production by the reducing action of ascorbic acid can also be evaluated using the “tyrosinase activity inhibition rate” shown in Example 3. The results are shown in Table 3. From Table 3, it is clear that by adding a small amount of ascorbic acid, the C18 adsorbed fraction and ascorbic acid act synergistically, and a small amount of C18 adsorbed fraction can provide a sufficient melanin production inhibitory effect. It was.
- the acerola fruit from which the seeds were removed was squeezed to obtain a fruit juice and a residue.
- this solution was applied to a synthetic adsorption resin (Amberlite XAD 7H P column), washed with distilled water, and then added with malic acid 70% Elute with ethanol solution. Thereafter, freeze drying was performed to obtain 5.9 kg of powder of the Acerola Labienol fraction.
- the total polyphenol content of this fraction (according to the Folin-Denis method) was about 40%. Obtained 1% of malic acid added to the eluate was contained in the powder of the Acerola labienol fraction.
- Results of Example 3 6 A drink containing celerolabriphenol is expected to be able to prevent or improve dullness and spots on the skin.
- the method for preparing such a drink is not particularly limited! For example, 200 ml of a drink can be prepared by a conventional method using 250 mg of the Acerola Labienol fraction prepared in Example 8.
- Test product A has the same composition as the control product.
- Test 1 subjects were given placebo samples.
- Test 2 Whitening effect
- Each test subject applied a control product to one arm and applied a predetermined test product to the other arm. An appropriate amount was applied once a day and continued for 2 weeks.
- test product C with 0.1% C18 adsorbed fraction content was the same as the test product D with 0.5%, and no difference was observed in the whitening effect.
- Test 1 if the color of test product D is too dark as a lotion, considering that it was pointed out, the addition amount of the C18 adsorbed fraction in the lotion should be about 0.1%. I can say that.
- Example 5 it was shown that the glycosides (cyanidine 3-rhamnoside and pelargodin 3-rhamnoside) of anthocyanin compounds contained in acerola have a tyrosinase activity inhibitory action.
- the tyrosinase activity inhibitory action was confirmed for the various Ich compounds shown in Table 7.
- shea-zin-3-rhamnoside, pelargo-zin-3-rhamnoside, quercetin-3-rhamnoside, isoquercitrin, istilbine, and hyperoside are polyphenols derived from acerola. . Shiaxin, pelargosine, delphidin, pauzin, and malvidin are anthocyanins. Isoquercitrin is an alternative name for quercetin 3-darcoside, istilbin is an alternative name for dehydrotaenorecitrin, and hyperoside is an alternative name for quercetin 3-galactoside.
- Inhibition rate (%) ⁇ 1— (initial velocity sample Z initial velocity control M X 100
- Table 8 shows sample ICs.
- siasin and pelargosine which are anthocyanin compounds
- tyrosinase activity inhibitory action was confirmed both as a glycoside and as a free form (chloride salt).
- the other anthocyanin compounds delphizine, pezine, and malvidin, have been confirmed to inhibit tyrosinase activity as free compounds (chloride salts), especially for pedinidine and malvidin. has been shown to be powerful.
- glycoside did not have an inhibitory effect on tyrosinase activity. In this respect, it was in contrast to anthocyanin compounds.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006531827A JPWO2006019114A1 (ja) | 2004-08-18 | 2005-08-17 | ポリフェノール化合物を含有する美白剤 |
EP05780368A EP1787624A4 (en) | 2004-08-18 | 2005-08-17 | SKIN LIGHTENING AGENT CONTAINING POLYPHENOL COMPOUND |
US11/708,021 US20070189997A1 (en) | 2004-08-18 | 2007-02-20 | Skin-whitening agent containing polyphenol compound |
US12/202,721 US20090004311A1 (en) | 2004-08-18 | 2008-09-02 | Skin-whitening agent containing polyphenol compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004238702 | 2004-08-18 | ||
JP2004-238702 | 2004-08-18 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/708,021 Continuation-In-Part US20070189997A1 (en) | 2004-08-18 | 2007-02-20 | Skin-whitening agent containing polyphenol compound |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006019114A1 true WO2006019114A1 (ja) | 2006-02-23 |
Family
ID=35907498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/015009 WO2006019114A1 (ja) | 2004-08-18 | 2005-08-17 | ポリフェノール化合物を含有する美白剤 |
Country Status (4)
Country | Link |
---|---|
US (2) | US20070189997A1 (ja) |
EP (1) | EP1787624A4 (ja) |
JP (1) | JPWO2006019114A1 (ja) |
WO (1) | WO2006019114A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214272A (ja) * | 2007-03-05 | 2008-09-18 | Oriza Yuka Kk | 美白剤 |
JP2009007261A (ja) * | 2007-06-26 | 2009-01-15 | Dainichiseika Color & Chem Mfg Co Ltd | 美白剤および化粧料組成物 |
JP2009256326A (ja) * | 2008-03-21 | 2009-11-05 | Kose Corp | 美白剤、及び皮膚外用剤 |
JP2010018530A (ja) * | 2008-07-09 | 2010-01-28 | Nihon Haruma Kk | リンゴ二次残渣物又はチシマザサを原料とするチロシナーゼ阻害活性剤の抽出方法及びそのチロシナーゼ阻害活性剤 |
JP2011001311A (ja) * | 2009-06-19 | 2011-01-06 | Pola Chemical Industries Inc | 熱産生タンパク質発現促進剤 |
JP2014221751A (ja) * | 2013-05-14 | 2014-11-27 | オリザ油化株式会社 | 美白剤 |
JP2015193595A (ja) * | 2014-03-25 | 2015-11-05 | 東洋インキScホールディングス株式会社 | 日焼け止め用水性分散組成物 |
JP2016060719A (ja) * | 2014-09-18 | 2016-04-25 | 二村 芳弘 | メラニン分解作用を呈するペラルゴニジン誘導体 |
JP2018138525A (ja) * | 2017-02-24 | 2018-09-06 | 株式会社ディーエイチシー | ビタミンcトランスポーター産生促進剤及びビタミンc吸収促進用組成物 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102469816A (zh) * | 2009-08-10 | 2012-05-23 | 斯托克里-丰康普公司 | 将类黄酮悬浮于饮料中的方法 |
TWI395468B (zh) * | 2009-12-30 | 2013-05-01 | Altek Corp | The method of eliminating the color dislocation of digital images |
WO2011144536A1 (en) | 2010-05-18 | 2011-11-24 | Unilever Nv | A personal care composition |
FR2961402B1 (fr) | 2010-06-17 | 2014-01-31 | Soliance | Compositions contenant des arabinoxylo-oligosaccharides et leurs utilisations |
CN111944165B (zh) * | 2020-07-15 | 2022-04-01 | 汕头大学 | 一种多酚类酪氨酸酶抑制剂及其提取方法和应用 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6248611A (ja) * | 1985-08-28 | 1987-03-03 | Shiseido Co Ltd | 皮膚外用剤 |
JPS62153211A (ja) * | 1985-12-26 | 1987-07-08 | Shiseido Co Ltd | 頭髪化粧料 |
JPH02200610A (ja) * | 1989-01-27 | 1990-08-08 | Nichirei Corp | アセロラエキスを含む化粧品 |
JPH0399090A (ja) * | 1989-08-11 | 1991-04-24 | Inverni Della Beffa Spa | 植物またはその抽出物からアントシアノシド類を高純度で含有する抽出物の調製方法 |
JP2000212032A (ja) * | 1999-01-26 | 2000-08-02 | Kose Corp | 美白用皮膚外用剤 |
JP2001046030A (ja) * | 1999-08-02 | 2001-02-20 | Tama Seikagaku Kk | ブルーベリー抽出エキスの製造法 |
JP2001328941A (ja) * | 2000-05-22 | 2001-11-27 | Yanai Yoshiaki | 抗ウィルス剤 |
JP2003508415A (ja) * | 1999-08-27 | 2003-03-04 | ミシガン ステイト ユニヴァーシティー | 天然シクロオキシゲナーゼ阻害剤を含有する食物サプリメント |
JP2003108979A (ja) * | 2001-09-27 | 2003-04-11 | Fuji Photo Film Co Ltd | 顔領域抽出方法および装置並びにプログラム |
WO2003033005A1 (de) * | 2001-10-15 | 2003-04-24 | Rudolf Wild Gmbh & Co. Kg | Konzentrat, umfassend grüntee, traubenschalenextrakt und traubenkernextrakt, seine herstellung und verwendung |
JP2004099578A (ja) * | 2002-09-04 | 2004-04-02 | Oriza Yuka Kk | 美肌用組成物 |
JP2004238345A (ja) * | 2003-02-07 | 2004-08-26 | Suzuko Uechi | 美容パック |
JP2005154432A (ja) * | 2003-11-05 | 2005-06-16 | Nichirei Corp | ポリフェノールおよび/またはビタミンcを含有するアセロラ処理物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3415198B2 (ja) * | 1993-06-30 | 2003-06-09 | 三省製薬株式会社 | 皮膚外用剤 |
US5747006A (en) * | 1997-05-14 | 1998-05-05 | Amway Corporation | Skin whitener composition containing acerola cherry fermentate |
US6818234B1 (en) * | 1999-08-27 | 2004-11-16 | Access Business Group International Llc | Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation |
US6759033B2 (en) * | 2000-06-22 | 2004-07-06 | Access Business Group International Llc | Method for slowing the decomposition of a cosmetic composition |
US6821536B2 (en) * | 2002-11-22 | 2004-11-23 | Quercegen Holdings Llc | Antioxidative compositions |
US20040166069A1 (en) * | 2003-02-21 | 2004-08-26 | Gupta Shyam K. | Boosting Tyrosinase Inhibiting Activity of Skin Whitening and Sunscreen Compositions |
-
2005
- 2005-08-17 WO PCT/JP2005/015009 patent/WO2006019114A1/ja active Application Filing
- 2005-08-17 JP JP2006531827A patent/JPWO2006019114A1/ja active Pending
- 2005-08-17 EP EP05780368A patent/EP1787624A4/en not_active Withdrawn
-
2007
- 2007-02-20 US US11/708,021 patent/US20070189997A1/en not_active Abandoned
-
2008
- 2008-09-02 US US12/202,721 patent/US20090004311A1/en not_active Abandoned
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6248611A (ja) * | 1985-08-28 | 1987-03-03 | Shiseido Co Ltd | 皮膚外用剤 |
JPS62153211A (ja) * | 1985-12-26 | 1987-07-08 | Shiseido Co Ltd | 頭髪化粧料 |
JPH02200610A (ja) * | 1989-01-27 | 1990-08-08 | Nichirei Corp | アセロラエキスを含む化粧品 |
JPH0399090A (ja) * | 1989-08-11 | 1991-04-24 | Inverni Della Beffa Spa | 植物またはその抽出物からアントシアノシド類を高純度で含有する抽出物の調製方法 |
JP2000212032A (ja) * | 1999-01-26 | 2000-08-02 | Kose Corp | 美白用皮膚外用剤 |
JP2001046030A (ja) * | 1999-08-02 | 2001-02-20 | Tama Seikagaku Kk | ブルーベリー抽出エキスの製造法 |
JP2003508415A (ja) * | 1999-08-27 | 2003-03-04 | ミシガン ステイト ユニヴァーシティー | 天然シクロオキシゲナーゼ阻害剤を含有する食物サプリメント |
JP2001328941A (ja) * | 2000-05-22 | 2001-11-27 | Yanai Yoshiaki | 抗ウィルス剤 |
JP2003108979A (ja) * | 2001-09-27 | 2003-04-11 | Fuji Photo Film Co Ltd | 顔領域抽出方法および装置並びにプログラム |
WO2003033005A1 (de) * | 2001-10-15 | 2003-04-24 | Rudolf Wild Gmbh & Co. Kg | Konzentrat, umfassend grüntee, traubenschalenextrakt und traubenkernextrakt, seine herstellung und verwendung |
JP2004099578A (ja) * | 2002-09-04 | 2004-04-02 | Oriza Yuka Kk | 美肌用組成物 |
JP2004238345A (ja) * | 2003-02-07 | 2004-08-26 | Suzuko Uechi | 美容パック |
JP2005154432A (ja) * | 2003-11-05 | 2005-06-16 | Nichirei Corp | ポリフェノールおよび/またはビタミンcを含有するアセロラ処理物 |
Non-Patent Citations (3)
Title |
---|
HANAMURA T. ET AL: "Acerola (Maloighia glabra L) Kajitsu ni Fukumareru Polyphenol Seibun no Kozo Kaiseki", ANNUAL MEETING OF JSBBA KOEN YOSHISHU, vol. 2004, 5 March 2004 (2004-03-05), pages 82 - 2A21P26, XP002988128 * |
See also references of EP1787624A4 * |
TSUDA T. ET AL: "Inhibitation of Tyrosinase activity by antocyanin pigments isolated from Phaseolus vulgaris L", FOOD SCI. TECHNOL. INT., vol. 3, no. 1, 1997, TOKYO, pages 82 - 83, XP002999862 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214272A (ja) * | 2007-03-05 | 2008-09-18 | Oriza Yuka Kk | 美白剤 |
JP2009007261A (ja) * | 2007-06-26 | 2009-01-15 | Dainichiseika Color & Chem Mfg Co Ltd | 美白剤および化粧料組成物 |
JP2009256326A (ja) * | 2008-03-21 | 2009-11-05 | Kose Corp | 美白剤、及び皮膚外用剤 |
JP2010018530A (ja) * | 2008-07-09 | 2010-01-28 | Nihon Haruma Kk | リンゴ二次残渣物又はチシマザサを原料とするチロシナーゼ阻害活性剤の抽出方法及びそのチロシナーゼ阻害活性剤 |
JP2011001311A (ja) * | 2009-06-19 | 2011-01-06 | Pola Chemical Industries Inc | 熱産生タンパク質発現促進剤 |
JP2014221751A (ja) * | 2013-05-14 | 2014-11-27 | オリザ油化株式会社 | 美白剤 |
JP2015193595A (ja) * | 2014-03-25 | 2015-11-05 | 東洋インキScホールディングス株式会社 | 日焼け止め用水性分散組成物 |
JP2016060719A (ja) * | 2014-09-18 | 2016-04-25 | 二村 芳弘 | メラニン分解作用を呈するペラルゴニジン誘導体 |
JP2018138525A (ja) * | 2017-02-24 | 2018-09-06 | 株式会社ディーエイチシー | ビタミンcトランスポーター産生促進剤及びビタミンc吸収促進用組成物 |
Also Published As
Publication number | Publication date |
---|---|
EP1787624A4 (en) | 2011-01-12 |
JPWO2006019114A1 (ja) | 2008-05-08 |
EP1787624A1 (en) | 2007-05-23 |
US20070189997A1 (en) | 2007-08-16 |
US20090004311A1 (en) | 2009-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006019114A1 (ja) | ポリフェノール化合物を含有する美白剤 | |
TW200902077A (en) | Whitening agent comprising equol or its saccharide derivative as an effective ingredient | |
US20110318397A1 (en) | Method for preparing high purity ginsenoside rd using lactobacillus casei and cosmetic composition for anti-wrinkle comprising the high purity ginsenoside rd | |
KR101928988B1 (ko) | 기능성 펩타이드와 발효물을 포함하는 피부 미백용 조성물 | |
JP2011246353A5 (ja) | ||
EP3135682A1 (en) | Glucosyl hesperidin, method for manufacturing same, and application for same | |
KR102034773B1 (ko) | 진세노사이드 Rh1, 진세노사이드 Rg2 및 수국 추출물을 포함하는 항염증 조성물 | |
KR100898758B1 (ko) | 항당뇨 활성을 나타내는 패과식물의 추출물 | |
KR20070021856A (ko) | 캄페롤을 유효성분으로 함유하는 피부 미백용 화장료조성물 | |
KR20180040756A (ko) | 율무 추출물을 포함하는 미백용 조성물 | |
EP1840131B1 (en) | Novel polyphenol glycoside derived from acerola | |
WO2022254867A1 (ja) | 新規フェニルプロパノイド化合物 | |
JP7239127B2 (ja) | 新規エラジタンニンおよび口腔用剤 | |
JP4136207B2 (ja) | 化粧料、医薬部外品、医薬品、食品 | |
JP5703313B2 (ja) | 3−ヒドロキシ−2−ピロンを含有する美白剤 | |
KR102244585B1 (ko) | 피부 노화 개선 복합 화장료 조성물 | |
KR101526435B1 (ko) | 머루근 추출물을 포함하는 미백용 조성물 | |
JP2000095642A (ja) | 美白化粧料 | |
KR102264006B1 (ko) | 멜라닌 생성 억제 및 분해 촉진용 조성물 | |
KR102014685B1 (ko) | 골담초 유래 화합물 및 이를 함유하는 피부 미백용 조성물 | |
KR102034779B1 (ko) | 진세노사이드 Rh1, 진세노사이드 Rg2 및 수국 추출물을 포함하는 피부 미백용 화장료 조성물 | |
KR102014646B1 (ko) | 골담초 유래 화합물 및 이를 함유하는 피부 미백용 조성물 | |
KR101711512B1 (ko) | 피부 개선용 조성물 | |
KR20230068905A (ko) | 흑생강(Kaempferia parviflora) 추출물로부터 분리된 화합물을 포함하는 미백기능성 조성물 | |
KR20210002046A (ko) | 구멍쇠미역 추출물을 포함하는 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006531827 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11708021 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005780368 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005780368 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11708021 Country of ref document: US |